“The American Medical Association is once again urging states, regulators and policymakers to waive limits and restrictions on prescriptions for opioid medication and other controlled substances during the COVID-19 pandemic.” PNN
The AMA urged states to adopt new DEA guidance giving more flexibility to physicians treating patients with opioid use disorder (OUD). deadiversion.usdoj.gov/GDP/(DEA-DC-02…
AMA COVID-19 policy recommendations for OUD, including states take a number of steps to make it easier to obtain pain medication during the pandemic, harm reduction.
Updated Dec. 8, 2020
The DEA published this notice of proposed rule on December 4, 2020 and there is a 60-day comment period thereafter. Partial Filling of Prescriptions for Schedule II Controlled Substances, 85 Fed. Reg. 78,282 (proposed Dec. 4, 2020).
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
21 CFR Part 1306 [Docket No. DEA–469] RIN 1117–AB45
Partial Filling of Prescriptions for Schedule II Controlled Substances
AGENCY: Drug Enforcement Administration, Department of Justice. govinfo.gov/content/pkg/FR…
Federal Register Electronic comments must be submitted, and written comments must be postmarked, on or before February 2, 2021. ⤵️ federalregister.gov/documents/2020…
Sedition is a federal offense, just sayin! ⤵️
“Her comment comes as 45 personally leaned on lawmakers/ state leaders, Ward included, following his election loss to Biden last month-45 urged them to take steps that would overturn states' election results. thehill.com/homenews/state…
HHS conceded laws, are “potentially inhibiting beneficial arrangements ➡️advance transition to value-based care/ improve coordination of patient care among providers➡️ across care settings in Federal health care programs ➡️ commercial sector.” seyfarth.com/news-insights/…
84 FR 55694 - Medicare and State Healthcare Programs: Fraud and Abuse; Revisions To Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements govinfo.gov/app/details/FR…
Public Hearing on Notice of Proposed Rulemaking 11/23/20
Agenda/ Public Hearing: Securing Updated and Necessary Statutory Evaluations Timely Notice of Proposed Rulemaking
November 23, 2020
10a.m. – 2 p.m. Eastern Time) Dial-in: +1-415-527-5035 (access code): 199 934 0311
Password: jB4kisMJt47 hhs.gov/sites/default/…
SUMMARY: This document announces a public hearing to receive information and views on the Notice of Proposed Rulemaking (NPRM) entitled “Securing Updated and Necessary Statutory Evaluations Timely.” public-inspection.federalregister.gov/2020-25246.pdf
CMS releases the Federal Meta-Evaluation Design for Section 1115 Substance Use Disorder (SUD) Demonstrations medicaid.gov/medicaid/downl…
(CMS) released an evaluation design that explains how the Agency will conduct a meta-analysis on Medicaid section 1115 Substance Use Disorder (SUD) demonstrations, which will be complete in the spring of 2023.
Section 1115 SUD demonstrations require states to increase access to SUD treatment services; increase capacity to provide services; implement widely recognized patient placement criteria and provider standards, care coordination policies, other prevention/treatment strategies.
Texas HHS Vendor Drug Vendor Reminder: "Quantity Prescribed" Required for Schedule II Drugs Beginning Sept. 21
September 2, 2020
Beginning Sept. 21, 2020, VDP will require the "Quantity Prescribed" field (460–ET) on all pharmacy claims for Schedule II drugs.
CMS published a final rule on Jan. 24, 2020
‘‘Administrative Simplification: Modification of the Requirements for the Use of Health Insurance Portability and Accountability Act of 1996 National Council for Prescription Drug Programs D.0 Standard’’